EE9900188A - HIV proteaasi inhibiitoritena kasulikud 1-(3-aminoindasool-5-üül)-3-fenüülmetüül-tsüklilised uuread - Google Patents

HIV proteaasi inhibiitoritena kasulikud 1-(3-aminoindasool-5-üül)-3-fenüülmetüül-tsüklilised uuread

Info

Publication number
EE9900188A
EE9900188A EEP199900188A EE9900188A EE9900188A EE 9900188 A EE9900188 A EE 9900188A EE P199900188 A EEP199900188 A EE P199900188A EE 9900188 A EE9900188 A EE 9900188A EE 9900188 A EE9900188 A EE 9900188A
Authority
EE
Estonia
Prior art keywords
hiv protease
aminoindazol
phenylmethyl
protease inhibitors
cyclic ureas
Prior art date
Application number
EEP199900188A
Other languages
English (en)
Estonian (et)
Inventor
David Rodgers James
Frank Iii Kaltenbach Robert
Original Assignee
Dupont Pharmaceuticals Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Pharmaceuticals Company filed Critical Dupont Pharmaceuticals Company
Publication of EE9900188A publication Critical patent/EE9900188A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EEP199900188A 1996-11-08 1997-11-04 HIV proteaasi inhibiitoritena kasulikud 1-(3-aminoindasool-5-üül)-3-fenüülmetüül-tsüklilised uuread EE9900188A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2974596P 1996-11-08 1996-11-08
US74710496A 1996-11-08 1996-11-08
PCT/US1997/020035 WO1998020008A1 (en) 1996-11-08 1997-11-04 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors

Publications (1)

Publication Number Publication Date
EE9900188A true EE9900188A (et) 1999-12-15

Family

ID=26705293

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900188A EE9900188A (et) 1996-11-08 1997-11-04 HIV proteaasi inhibiitoritena kasulikud 1-(3-aminoindasool-5-üül)-3-fenüülmetüül-tsüklilised uuread

Country Status (21)

Country Link
EP (1) EP0937067B1 (pt)
JP (1) JP2001503428A (pt)
KR (1) KR20000053122A (pt)
CN (1) CN1235602A (pt)
AT (1) ATE244714T1 (pt)
AU (1) AU5165198A (pt)
BR (1) BR9712910A (pt)
CA (1) CA2270966A1 (pt)
CZ (1) CZ157599A3 (pt)
DE (1) DE69723456T2 (pt)
EA (1) EA199900452A1 (pt)
EE (1) EE9900188A (pt)
ES (1) ES2202645T3 (pt)
HU (1) HUP9904676A2 (pt)
IL (1) IL129727A0 (pt)
LV (1) LV12375B (pt)
NO (1) NO992228L (pt)
PL (1) PL333421A1 (pt)
SI (1) SI20074A (pt)
SK (1) SK59699A3 (pt)
WO (1) WO1998020008A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2282593A1 (en) * 1997-03-31 1998-10-08 Du Pont Pharmaceuticals Company Indazoles of cyclic ureas useful as hiv protease inhibitors
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
CA2635813C (en) 2006-01-31 2014-01-07 Array Biopharma, Inc. Urea derivatives as kinase inhibitors and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5532357A (en) * 1995-06-07 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas

Also Published As

Publication number Publication date
PL333421A1 (en) 1999-12-06
LV12375B (en) 2000-04-20
LV12375A (lv) 1999-11-20
JP2001503428A (ja) 2001-03-13
WO1998020008A1 (en) 1998-05-14
EA199900452A1 (ru) 2000-02-28
NO992228D0 (no) 1999-05-07
NO992228L (no) 1999-06-07
EP0937067B1 (en) 2003-07-09
SK59699A3 (en) 1999-12-10
DE69723456T2 (de) 2004-05-27
DE69723456D1 (de) 2003-08-14
IL129727A0 (en) 2000-02-29
BR9712910A (pt) 2000-03-21
ES2202645T3 (es) 2004-04-01
KR20000053122A (ko) 2000-08-25
CN1235602A (zh) 1999-11-17
CA2270966A1 (en) 1998-05-14
CZ157599A3 (cs) 1999-11-17
SI20074A (sl) 2000-04-30
ATE244714T1 (de) 2003-07-15
AU5165198A (en) 1998-05-29
HUP9904676A2 (hu) 2000-06-28
EP0937067A1 (en) 1999-08-25

Similar Documents

Publication Publication Date Title
WO1998045276A3 (en) 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinones useful as hiv reverse transcriptase inhibitors
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
PT966465E (pt) Inibidores do enzima imfdh
BG100455A (en) Hiv protease inhibitors
DE69124371T2 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
AP2003002915A0 (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis.
DE69823344D1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
BR9806752A (pt) Ftalazinonas.
ATE298741T1 (de) Polyaromatische verbindungen zur behandlung von herpes-infektionen
EE200200208A (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
ATE423562T1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
ATE232873T1 (de) Phosphonsaürederivate als ptp-1b-inhibitoren
ES2243579T3 (es) Derivados de pirazolopirideno.
ES2151600T3 (es) Derivados de n-(3-amino-2-hidroxibutil)sulfonamida utilizados como inhibidores de proteasa de vih.
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
YU62504A (sh) Triciklična 2-pirimidonska jedinjenja korisna kao inhibitori hiv reverzne transkriptoze
ATE253359T1 (de) Antithrombotische mittel
BR9813719A (pt) Agentes terapêuticos
TR200003065T2 (tr) Nöraminidazların inhibitörleri olarak pirolidinler.
EE9900188A (et) HIV proteaasi inhibiitoritena kasulikud 1-(3-aminoindasool-5-üül)-3-fenüülmetüül-tsüklilised uuread
SE9904128D0 (sv) Novel compounds
LT2003003A (en) Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors
SE9604582D0 (sv) Novel compounds
DE69828522D1 (de) Antithrombotische mittel
LV12374A (lv) (4R,5S,6S,7R)-Heksahidro-1-(5-(3-aminoindazol)metil)-3-butil-5,6-dioksi-4,7-bis(fenilmetil)-2H-1,3-diazepin-2-ons si savienojuma iegusana un ka HIV proteazes inhibitora pielietojums